Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-01-29
1995-07-11
Lone, Werren B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514206, 514249, A61K 3147, A01N 4340
Patent
active
054321824
ABSTRACT:
Substituted 4-aminoquinazoline derivatives which are inhibitors of gastric acid secretion. A compound of the invention are the salts of strong acids of 3-butyryl-4-(2-methylphenylamino)-8-(hydroxymethyl)quinoline.
REFERENCES:
patent: 4343804 (1982-08-01), Munson, Jr. et al.
Ife, et al. Chemical Abstracts vol. 112(17)158,073s Apr. 23, 1990.
Ife, et al. "Chemical Abstracts" vol. 117(23) 233,869g 1992.
Grundler, et al. "Chemical Abstracts" vol. 119(21) 225,851d Nov. 29, 1993.
Ife Robert J.
Leach Colin A.
Dinner Dara L.
Lentz Edward T.
Lone Werren B.
SmithKline Beecham Intercredit B.V.
Venetianer Stephen
LandOfFree
Compounds substituted quinoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds substituted quinoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds substituted quinoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-503638